Tumor budding is defined as the presence of single tumor cells or small tumor clusters (less than five cells) that ‘bud’ from the invasive front of the main tumor. Tumor budding (TB) has recently emerged as an important adverse prognostic factor for many different cancer types. In colorectal carcinoma (CRC), tumor budding has been independently associated with lymph node metastasis and poor outcome. Pathologic assessment of tumor budding by light microscopy requires close evaluation of tumor invasive front on intermediate to high power magnification, entailing locating the ‘hotspot’ of tumor budding, counting all TB in one high power field, and generating a tumor budding score. By automating these time-consuming tasks, computer-assisted image analysis tools can be helpful for daily pathology practice, since tumor budding reporting is now recommended on select cases. In this paper, we report our work on the development of a tumor budding detection system in CRC from whole-slide Cytokeratin AE1/3 images, based on de novo computer algorithm that automates morphometric analysis of tumor budding.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
Boxberg, M., Jesinghaus, M., Dorfner, C., Mogler, C., Drecoll, E., Warth, A., Steiger, K., Bollwein, C., Meyer, P., Wolff, K. D., Kolk, A., and Weichert, W., Tumour budding activity and cell nest size determine patient outcome in oral squamous cell carcinoma: Proposal for an adjusted grading system. Histopathology 70(7):1125–1137, 2017.
Angadi, P. V., Patil, P. V., Hallikeri, K., Mallapur, M. D., Hallikerimath, S., and Kale, A. D., Tumor budding is an independent prognostic factor for prediction of lymph node metastasis in oral squamous cell carcinoma. Int. J. Surg. Pathol. 23(2):102–110, 2015.
Li, X., Wei, B., Sonmez, C., Li, Z., and Peng, L., High tumor budding count is associated with adverse clinicopathologic features and poor prognosis in breast carcinoma. Hum. Pathol. 66:222–229, 2017.
Jesinghaus, M., Boxberg, M., Konukiewitz, B., Slotta-Huspenina, J., Schlitter, A. M., Steiger, K., Specht, K., Wieczorek, K., Warth, A., Schmidt, T., Hartmann, A., Demir, I. E., Feith, M., Ott, K., and Weichert, W., A novel grading system based on tumor budding and cell Nest size is a strong predictor of patient outcome in esophageal squamous cell carcinoma. Am. J. Surg. Pathol. 41(8):1112–1120, 2017.
Che, K., Zhao, Y., Qu, X., Pang, Z., Ni, Y., Zhang, T., du, J., and Shen, H., Prognostic significance of tumor budding and single cell invasion in gastric adenocarcinoma. OncoTargets Ther. 10:1039–1047, 2017.
Olsen, S., Linda, J., Fields, R. C., Yan, Y., and Nalbantoglu, I., Tumor budding in intestinal type gastric adenocarcinoma is associated with nodal metastasis and recurrence. Hum. Pathol. 68:26–33, 2017.
Huang, B., Cai, J., Xu, X., Guo, S., and Wang, Z., High-grade tumor budding stratifies early-stage cervical Cancer with recurrence risk. PLoS One 11(11):e0166311, 2016.
Satabongkoch, N., Khunamornpong, S., Pongsuvareeyakul, T., Settakorn, J., Sukpan, K., Soongkhaw, A., intaraphet, S., Suprasert, P., and Siriaunkgul, S., Prognostic value of tumor budding in early-stage cervical adenocarcinomas. Asian Pac. J. Cancer Prev. 18(6):1717–1722, 2017.
Lai, Y. H., Wu, L. C., Li, P. S., Wu, W. H., Yang, S. B., Xia, P., He, X. X., and Xiao, L. B., Tumour budding is a reproducible index for risk stratification of patients with stage II colon cancer. Color. Dis. 16(4):259–264, 2014.
Mezheyeuski, A., Hrynchyk, I., Karlberg, M. et al., Image analysis-derived metrics of histomorphological complexity predicts prognosis and treatment response in stage II-III colon cancer. Sci. Rep. 6:36149, 2016.
Zlobec, I., Hädrich, M., Dawson, H., Koelzer, V. H., Borner, M., Mallaev, M., Schnüriger, B., Inderbitzin, D., and Lugli, A., Intratumoural budding (ITB) in preoperative biopsies predicts the presence of lymph node and distant metastases in colon and rectal cancer patients. Br. J. Cancer 110(4):1008–1013, 2014.
Cappellesso, R., Luchini, C., Veronese, N., Lo Mele, M., Rosa-Rizzotto, E., Guido, E., de Lazzari, F., Pilati, P., Farinati, F., Realdon, S., Solmi, M., Fassan, M., and Rugge, M., Tumor budding as a risk factor for nodal metastasis in Pt1 colorectal cancers: A meta-analysis. Hum. Pathol. 65:62–70, 2017.
Graham, R. P., Vierkant, R. A., Tillmans, L. S., Wang, A. H., Laird, P. W., Weisenberger, D. J., Lynch, C. F., French, A. J., Slager, S. L., Raissian, Y., Garcia, J. J., Kerr, S. E., Lee, H. E., Thibodeau, S. N., Cerhan, J. R., Limburg, P. J., and Smyrk, T. C., Tumor budding in colorectal carcinoma: Confirmation of prognostic significance and histologic cutoff in a population-based cohort. Am. J. Surg. Pathol. 39(10):1340–1346, 2015.
Koelzer, V. H., Zlobec, I., Berger, M. D. et al., Tumor budding in colorectal cancer revisited: Results of a multicenter interobserver study. Virchows Arch. 466:485–493, 2015.
Koelzer, V. H., Zlobec, I., and Lugli, A., Tumor budding in colorectal cancer—Ready for diagnostic practice? Hum. Pathol. 47(1):4–19, 2016.
Petrelli, F., Pezzica, E., Cabiddu, M., Coinu, A., Borgonovo, K., Ghilardi, M., Lonati, V., Corti, D., and Barni, S., Tumour budding and survival in stage II colorectal cancer: A systematic review and pooled analysis. J. Gastrointestin. Cancer 46(3):212–218, 2015.
Lugli, A., Kirsch, R., Ajioka, Y., Bosman, F., Cathomas, G., Dawson, H., el Zimaity, H., Fléjou, J. F., Hansen, T. P., Hartmann, A., Kakar, S., Langner, C., Nagtegaal, I., Puppa, G., Riddell, R., Ristimäki, A., Sheahan, K., Smyrk, T., Sugihara, K., Terris, B., Ueno, H., Vieth, M., Zlobec, I., and Quirke, P., Recommendations for reporting tumor budding in colorectal cancer based on the international tumor budding consensus conference (ITBCC) 2016. Mod. Pathol. 30(9):1299–1311, 2017.
Prall, F., Tumour budding in colorectal carcinoma. Histopathology 50(1):151–162, 2007.
Grizzi, F., Celesti, G., Basso, G., and Laghi, L., Tumor budding as a potential histopathological biomarker in colorectal cancer: Hype or hope? World J. Gastroenterol. 18(45):6532–6536, 2012.
Siegel, R. L., Miller, K. D., and Jemal, A., Cancer statistics. CA Cancer J. Clin. 69(1):7–34, 2019.
Koelzer, V. H., Assarzadegan, N., Dawson, H., Mitrovic, B., Grin, A., Messenger, D. E., Kirsch, R., Riddell, R. H., Lugli, A., and Zlobec, I., Cytokeratin-based assessment of tumour budding in colorectal cancer: Analysis in stage II patients and prospective diagnostic experience. J. Pathol. Clin. Res. 3(3):171–178, 2017.
Rieger, G., Koelzer, V. H., Dawson, H. E. et al., Comprehensive assessment of tumour budding by cytokeratin staining in colorectal cancer. Histopathology 70:1044–1051, 2017.
Mezheyeuski, A. et al., Image analysis-derived metrics of histomorphological complexity predicts prognosis and treatment response in stage II-III colon cancer. Sci. Rep. 6:36149, 2016.
Jepsen, R. K., Klarskov, L. L., Lippert, M. F. et al., Digital image analysis of pan-cytokeratin stained tumor slides for evaluation of tumor budding in pT1/pT2 colorectal cancer: Results of a feasibility study. Pathol. Res. Pract., 2018. https://doi.org/10.1016/j.prp.2018.07.002.
The first author would like to thank the Fulbright program, the Malaysian Communications and Multimedia Commission, the Fundamental Research Grant Scheme of the Ministry of Higher Education Malaysia (FRGS 2015-1), and the Ohio State University Wexner Medical Center for providing support to conduct this research project.
This study was supported in part by OSU CCC Pelotonia Award. Mohammad Faizal Ahmad Fauzi also received support from the Fulbright program, the Malaysian Communications and Multimedia Commission and the Fundamental Research Grant Scheme of the Ministry of Higher Education Malaysia (FRGS 2015–1) to conduct this research at the Ohio State University Wexner Medical Center.
Conflict of interest
Mohammad Faizal Ahmad Fauzi declares that he has no conflict of interest. Wei Chen declares that she has no conflict of interest. Debbie Knight declares that she has no conflict of interest. Heather Hampel declares that she has no conflict of interest. Wendy L. Frankel declares that she has no conflict of interest. Metin N. Gurcan declares that he has no conflict of interest.
This article does not contain any studies with human participants or animals performed by any of the authors.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Image & Signal Processing
About this article
Cite this article
Fauzi, M.F.A., Chen, W., Knight, D. et al. Tumor Budding Detection System in Whole Slide Pathology Images. J Med Syst 44, 38 (2020). https://doi.org/10.1007/s10916-019-1515-y
- Tumor budding
- Colorectal cancer
- Tumor classification
- Digital pathology